Difference between revisions of "MRE Biomarker Ctte"
Jump to navigation
Jump to search
| Line 15: | Line 15: | ||
'''Approved call summaries:''' | '''Approved call summaries:''' | ||
| + | Note: The last meeting of this group was held on April 1, 2019; notes are posted after they are approved during the following t-con | ||
*[[Media:2018_11-20_QIBA_MRE_BC_Call_Summary-FINAL.pdf|November 20, 2018]] | *[[Media:2018_11-20_QIBA_MRE_BC_Call_Summary-FINAL.pdf|November 20, 2018]] | ||
*[[Media:2018_04-09_QIBA_MRE_BC_Call_Summary-FINAL.pdf|April 9, 2018]] | *[[Media:2018_04-09_QIBA_MRE_BC_Call_Summary-FINAL.pdf|April 9, 2018]] | ||
Revision as of 20:22, 31 May 2019
- Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD
- RSNA Staff Support: Susan Stanfa
Project Snapshot
The MRE Biomarker Committee seeks to develop a quantitative Profile for MRE.
MRE Profile to be data-driven:
- focusing on the characterization of bias and precision in MRE measurement targets for achieving these measurements
- focusing on issues important to specific reproducibility
Meetings
Approved call summaries: Note: The last meeting of this group was held on April 1, 2019; notes are posted after they are approved during the following t-con
MRE Profile Development